Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Post by Tigerwoods3672on Sep 20, 2019 7:46pm
227 Views
Post# 30150366

Canadia Deal.

Canadia Deal.

If you look at the history of the stock price,  the 4 month holding period ended in February the price has been in a decline since then (which means they are unloading shares now??)  They gave 10 Million dollars for expansion for working capital for Canadia AND NOW SOLD OFF CANANDIA.  

Could someone dumb this down for me? Am I reading this correctly?

The exercise price of the Option (the "Exercise Price") was as follows:

a)    

$2.4 million in common shares of the Company (the "First Consideration Common Shares") at $1.32 per common share. The First Consideration Common Shares will be subject to a 4 month hold period;

b) 

$10 million in common shares of the Company (the "Second Consideration Common Shares") at $1.65 per common share with the following release schedule:

   
 

a.

25% of the Second Consideration Common Shares on the closing; and

 

  

b. 

25% of the Second Consideration Common Shares every 4 months thereafter.

   

c) 

$10 million investment (the "Investment") in cash into Canandia to be used for expansion of the Mission Location and working capital purposes. The Investment will be paid into Canandia over time on an as-needed basis; and

d) 

$7 million in common shares of the Company issued to the Vendors on the date that is within 10 business days of the Mission Location receiving its cultivation license under the Cannabis Act and Cannabis Regulations, valued at the greater of $1.06 per share and the 10 trading days Volume Weighted Average Price ("VWAP") on the TSXV immediately prior to the License Date.

Thanks for reading.
<< Previous
Bullboard Posts
Next >>